Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Míreanna comhchosúla

• Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
  de réir: Xu, S, et al.
  Foilsithe / Cruthaithe: (2021)
• Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
  de réir: Wamil, M, et al.
  Foilsithe / Cruthaithe: (2020)
• Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
  de réir: Leal, J, et al.
  Foilsithe / Cruthaithe: (2022)
• Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
  de réir: Holman, R, et al.
  Foilsithe / Cruthaithe: (2017)
• Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
  de réir: Currie, G, et al.
  Foilsithe / Cruthaithe: (2017)